SCHEMBL20903641

SCHEMBL20903641

Cc1cc2ncccc2c2nc(-c3ccccc3)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.46
CCR8 P51685 2/20 0.46
NPC1 O15118 4/20 0.44
PDGFRB P09619 1/20 0.44
KDR P35968 1/20 0.44
FLT3 P36888 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TOP1 P11387 1/20 0.43
SYK P43405 3/20 0.41
KDM4E B2RXH2 1/20 0.40
PSMB5 P28074 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1B1 Q16678 1/20 0.39
PDE10A Q9Y233 1/20 0.39
CCR5 P51681 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21032002 0.81 CCR1 (0.64) CCR1CCR8NPC1PDGFRBKDR
SCHEMBL21031257 0.79 CCR1 (0.60) CCR1CCR8NPC1TOP1CCR5
SCHEMBL127144 0.78 TOP1 (0.49) CCR1CCR8NPC1RAB9ATOP1
SCHEMBL8654916 0.78 CCR1 (0.61) CCR1CCR8NPC1SMN1; SMN2KDM4E
SCHEMBL669488 0.77 LMNA (0.61) CCR1CCR8NPC1RAB9ASMN1; SMN2
SCHEMBL12655491 0.77 TOP1 (0.47) NPC1RAB9ATOP1L3MBTL1MEN1
SCHEMBL15998544 0.75 TOP1 (0.46) NPC1RAB9ATOP1MEN1KMT2A
SCHEMBL27820373 0.75 LMNA (0.57) CCR1CCR8NPC1RAB9ASMN1; SMN2
SCHEMBL12315219 0.74 ALDH1A1 (0.56) NPC1PDGFRBKDRFLT3RAB9A
SCHEMBL16678847 0.74 ALDH1A1 (0.49) RAB9ASMN1; SMN2KDM4EL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470494-A1 OLED COMPRISING ORGANIC COMPOUNDS CONTAINING B-N HETEROCYCLES Universal Display Corporation (US) 2019-04-17 EP disclosed